Currently, there are 93.40M common shares owned by the public and among those 90.93M shares have been available to trade.
The company’s stock has a 5-day price change of -22.59% and -35.22% over the past three months. NEP shares are trading -47.39% year to date (YTD), with the 12-month market performance down to -32.23% lower. It has a 12-month low price of $17.07 and touched a high of $35.15 over the same period. NEP has an average intraday trading volume of 1.68 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -23.44%, -33.03%, and -41.45% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of NextEra Energy Partners LP (NYSE: NEP) shares accounts for 61.08% of the company’s 93.40M shares outstanding.
It has a market capitalization of $2.99B and a beta (3y monthly) value of 1.03. The stock’s trailing 12-month PE ratio is 7.33, while the earnings-per-share (ttm) stands at $2.18. Price movements for the stock have been influenced by the stock’s volatility, which stands at 5.44% over the week and 4.41% over the month.
Earnings per share for the fiscal year are expected to decrease by -9.61%, and 22.64% over the next financial year.
Looking at the support for the NEP, a number of firms have released research notes about the stock. Guggenheim stated their Neutral rating for the stock in a research note on October 28, 2024, with the firm’s price target at $37-$22. JP Morgan coverage for the NextEra Energy Partners LP (NEP) stock in a research note released on October 24, 2024 offered a Neutral rating with a price target of $22. Exane BNP Paribas was of a view on October 01, 2024 that the stock is Underperform, while Jefferies gave the stock Buy rating on September 19, 2024, issuing a price target of $28. Morgan Stanley on their part issued Underweight rating on July 31, 2024.
